Critical illness myopathy in intensive care patients: Pathogenetic concepts and clinical management;"Critical illness myopathy" bei intensivpatienten: Pathogenetische konzepte und klinisches management

Anaesthesist

Volumn 55, Issue 12, 2006, Pages 1271-1280

  Friedrich, O ^b   Hund, E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antioxidative capacity; Critical illness; Insulin therapy; Myopathy; Pathomechanisms

Indexed keywords

BRAIN DISEASE; CENTRAL NERVOUS SYSTEM; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; MYOPATHY; PERIPHERAL NERVOUS SYSTEM; POLYNEUROPATHY; PRIMARY MEDICAL CARE; REVIEW; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS; CRITICAL ILLNESS; ENERGY METABOLISM; HUMANS; INTENSIVE CARE; MUSCULAR DISEASES; MYOSINS; NEUROMUSCULAR DISEASES; NEUROMUSCULAR JUNCTION; SEPSIS; STEROIDS;

EID: 33845892745     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-006-1100-x     Document Type: Review

References (46)

1. Bednarik J, Lukas Z, Vondracek P (2003) Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Crit Care Med 29: 1505-1514
2. Bentzer P, Grände PO (2004) Low-dose prostacyclin restores an increased protein permeability after trauma in cat skeletal muscle. J Trauma 56: 385-392
3. Berchtold MW, Brinkmeier H, Müntener M (2000) Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity and disease. Physiol Rev 80: 1215-1265
4. Bercker S, Weber-Carstens S, Deja M et al. (2005) Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 33: 711-715
5. Berghe G van den (2004) How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114: 1187-1195
6. Berghe G van den, Wouters PJ, Weekers F et al. (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345: 1359-1367
7. Berghe G van den, Schoonheydt K, Becx P et al. (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64: 1348-1353
8. Bolton CF (2005) Neuromuscular manifestations of critical illness. Muscle Nerve 32: 140-163
9. Brealey D, Brand M, Hargreaves I et al. (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360: 219-223
10. Caruso P, Denari SD, Ruiz SA et al. (2005) Inspiratory muscle training is ineffective in mechanically ventilated critically ill patients. Clinics 60: 479-484
11. Filatov G, Rich MM (2004) Hyperpolarized shifts in the voltage dependence of fast inactivation of NaV1.4 and NaV1.5 in a rat model of critical illness myopathy. J Physiol 559: 813-820
12. Friedrich O (2006) Critical illness myopathy: what is happening? Curr Opin Clin Nutr Metab Care 9: 403-409
13. Friedrich O, Hund E, Weber C et al. (2004) Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle. J Neurol 251: 53-65
14. Friedrich O, Fink RH, Hund E (2005) Understanding critical illness myopathy: approaching the pathomechanism. J Nutr 135: 1813S-1817S
15. Ganitkevich VY (2003) The role of mitochondria in cytoplasmic Ca2+ cycling. Exp Physiol 88: 91-97
16. Ginz HF, Iaizzi PA, Girard T et al. (2005) Decreased isometric skeletal muscle force in critically ill patients. Swiss Med Wkly 135: 555-561
17. Giovanni S di, Molon A, Broccolini A et al. (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55: 195-206
18. Guttridge DC, Mayo MW, Madrid LV et al. (2000) NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289: 2363-2366
19. Herridge MS, Cheung AM, Tansey CM et al. (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348: 683-693
20. Horinouchi H, Kumamoto T, Kimura N et al. (2005) Myosin loss in denervated rat soleus muscle after dexamethasone treatment. Pathobiology 72: 108-116
21. Hund E (2001) Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248: 929-934
22. Jonghe B de, Bastuji-Garin S, Sharshar T et al. (2004) Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 30: 1117-1121
23. Kerbaul F, Brousse M, Collart F et al. (2004) Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes. Crit Care 8: R358-366
24. Klaude M, Hammarqvist F, Wernerman J (2005) An assay of microsomal membrane-associated proteasomes demonstrates increased proteolytic activity in skeletal muscle of intensive care unit patients. Clin Nutr 24: 259-265
25. Lacomis D, Zochodne DW, Bird SJ (2000) Critical illness myopathy (editorial). Muscle Nerve 23: 1785-1788
26. Laghi F, Tobin J (2003) Disorders of the respiratory muscles. Am J Respir Crit Care Med 168: 10-48
27. Lanone S, Mebazaa A, Heymes C et al. (2000) Muscular contractile failure in septic patients. Am J Respir Crit Care Med 162: 2308-2315
28. Latronico N (2003) Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med 29: 1411-1413
29. Latronico N, Peli E, Botteri M (2005) Critical illness myopathy and neuropathy. Curr Opin Crit Care 11: 126-132
30. Lee MC, Wee GR, Kim JH (2005) Apoptosis of skeletal muscle on steroid-induced myopathy in rats. J Nutr 135: 1806S-1808S
31. Lefaucheur JP, Nodine T, Rodriguez P, Brochard L (2006) Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77: 500-506
32. Letter MA de, Doorn PA van, Savelkoul HF et al. (2000) Critical illness polyneuropathy and myopathy (CIPNM): evidence for a local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 106: 206-213
33. Leung TW, Wong KS, Hui AC et al. (2005) Myopathic changes associated with severe acute respiratory syndrome. Arch Neurol 62: 1113-1117
34. Maramattom B, Wijdicks EF, Sundt TM, Cassivi SD (2004) Flaccid quadriplegia due to necrotizing myopathy following lung transplantation. Transplant Proc 36: 2830-2833
35. Mesotten D, Swinnen JV, Vanderhoydonc F et al. (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89: 219-226
36. Novak F, Heyland DK, Avenell A et al. (2002) Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 30: 2022-2029
37. Ortolani O, Conti A, Gaudio AR de (2000) The effect of glutathione and N-acetylcysteine on liperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 161: 1907-1911
38. Reid CL, Campbell IT, Little RA (2004) Muscle wasting and energy balance in critical illness. Clin Nutr 23: 273-280
39. Reinhart K, Karzai W (2001) Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 29: S121-125
40. Rich MM, Pinter MJ (2003) Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 547: 555-566
41. Rich MM, Bird SJ, Raps EC et al. (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20: 665-673
42. Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524
43. Roth GA, Moser B, Krenn C et al. (2005) Heightened levels of circulating 20S proteasome in critically ill patients. Eur J Clin Invest 35: 399-403
44. Stibler H, Edström L, Ahlbeck K et al. (2003) Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 29: 1515-1527
45. Wilmore DW, Shabert JK (1998) Role of glutamine in immunologic responses. Nutrition 14: 618-626
46. Williams AB, Decourten-Myers GM, Fischer JE et al. (1999) Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J 13: 1435-1443